Yabao Pharmaceutical Group Co Ltd (600351) — Cash Flow Quality Index
Yabao Pharmaceutical Group Co Ltd (600351) has a Cash Flow Quality Index of 3.18x as of September 2025. Operating cash flow of CN¥129.49 Million exceeds net income of CN¥40.70 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Yabao Pharmaceutical Group Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Yabao Pharmaceutical Group Co Ltd Cash Flow Quality Index (2001–2024)
Historical Cash Flow Quality Index for Yabao Pharmaceutical Group Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Yabao Pharmaceutical Group Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Yabao Pharmaceutical Group Co Ltd (2001–2024)
Year-by-year earnings quality comparison for Yabao Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see Yabao Pharmaceutical Group Co Ltd (600351) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.11x | CN¥471.69 Million | CN¥223.92 Million | ▼ -15.5% |
| 2023 | 2.49x | CN¥497.55 Million | CN¥199.59 Million | ▼ -43.4% |
| 2022 | 4.40x | CN¥460.46 Million | CN¥104.60 Million | ▲ +84.9% |
| 2021 | 2.38x | CN¥437.50 Million | CN¥183.76 Million | ▼ -31.9% |
| 2020 | 3.50x | CN¥380.96 Million | CN¥108.99 Million | ▼ -91.1% |
| 2019 | 39.37x | CN¥425.17 Million | CN¥10.80 Million | ▲ +2521.3% |
| 2018 | 1.50x | CN¥426.60 Million | CN¥284.02 Million | ▲ +85.6% |
| 2017 | 0.81x | CN¥161.73 Million | CN¥199.82 Million | ▼ -86.0% |
| 2016 | 5.77x | CN¥155.95 Million | CN¥27.04 Million | ▲ +776.6% |
| 2015 | 0.66x | CN¥143.47 Million | CN¥218.05 Million | ▼ -39.2% |
| 2014 | 1.08x | CN¥178.63 Million | CN¥165.11 Million | ▲ +115.7% |
| 2013 | 0.50x | CN¥56.80 Million | CN¥113.26 Million | ▲ +157.0% |
| 2012 | -0.88x | CN¥-96.73 Million | CN¥109.87 Million | ▼ -526.8% |
| 2011 | 0.21x | CN¥40.73 Million | CN¥197.41 Million | ▲ +54.9% |
| 2010 | 0.13x | CN¥18.57 Million | CN¥139.40 Million | ▼ -95.4% |
| 2009 | 2.88x | CN¥368.56 Million | CN¥128.16 Million | ▲ +142.5% |
| 2008 | 1.19x | CN¥102.90 Million | CN¥86.76 Million | ▼ -46.2% |
| 2007 | 2.20x | CN¥105.69 Million | CN¥47.95 Million | ▲ +169.6% |
| 2006 | 0.82x | CN¥11.59 Million | CN¥14.18 Million | ▼ -47.7% |
| 2005 | 1.56x | CN¥26.40 Million | CN¥16.88 Million | ▼ -34.0% |
| 2004 | 2.37x | CN¥79.73 Million | CN¥33.63 Million | ▲ +708.2% |
| 2003 | -0.39x | CN¥-9.62 Million | CN¥24.68 Million | ▼ -132.0% |
| 2002 | 1.22x | CN¥24.29 Million | CN¥19.94 Million | ▼ -5.7% |
| 2001 | 1.29x | CN¥23.59 Million | CN¥18.26 Million | — |